3.1 Hepatobiliary Disorders, Peptic Ulcers & Inflammatory Bowel Disease
Key Takeaways
- H. pylori eradication requires triple therapy (PPI, clarithromycin, amoxicillin/metronidazole) for 14 days, reflecting common practice in Saudi Arabia.
- Ulcerative colitis typically presents with bloody diarrhea and always involves the rectum, extending proximally in a continuous fashion.
- Crohn's disease can involve any part of the GI tract from mouth to anus, typically sparing the rectum, and presents with skip lesions and transmural inflammation.
- Acute cholecystitis management requires initial conservative management (IV fluids, antibiotics) followed by early laparoscopic cholecystectomy.
- Hepatitis B profile interpretation is crucial: HBsAg indicates infection, Anti-HBs indicates immunity, and Anti-HBc IgM indicates acute infection.
Hepatobiliary Disorders, Peptic Ulcers & Inflammatory Bowel Disease
Gastroenterology and hepatology represent a major component (~30%) of the Internal Medicine section of the SMLE. Candidates must be proficient in managing acute abdominal conditions, interpreting viral hepatitis panels, differentiating inflammatory bowel diseases, and executing acute resuscitation for upper gastrointestinal hemorrhages.
Hepatobiliary Pathology & Viral Hepatitis
Viral Hepatitis Serological Panels
Interpreting Hepatitis B virus (HBV) serology is one of the most frequently tested topics on the SMLE:
| Serological Marker | Clinical Significance & Interpretation |
|---|---|
| HBsAg (Surface Antigen) | Indicates active infection (acute or chronic if present >6 months). First marker to appear. |
| Anti-HBs (Surface Antibody) | Indicates immunity (due to resolved natural infection or vaccination). |
| Anti-HBc IgM (Core Antibody IgM) | Marker of acute infection or active viral replication during the "window period" (when HBsAg has disappeared but Anti-HBs is not yet detectable). |
| Anti-HBc IgG (Core Antibody IgG) | Indicates past exposure or chronic infection. (Positive in resolved infection; negative in vaccinated individuals). |
| HBeAg (Envelope Antigen) | Marker of high infectivity and active, ongoing viral replication. |
| HBV DNA (Viral Load) | Quantifies active replication; guides candidacy for antiviral therapy (e.g., Tenofovir, Entecavir). |
Hepatitis Serology Interpretation Matrix:
- Vaccinated Individual: Anti-HBs Positive; all other markers Negative.
- Resolved Past Infection: Anti-HBs Positive, Anti-HBc IgG Positive; HBsAg Negative.
- Chronic Active Infection: HBsAg Positive (>6 months), Anti-HBc IgG Positive, HBeAg Positive/Negative, Anti-HBs Negative.
Gallstone Spectrum & Biliary Tree Infections
- Biliary Colic: Episodic, postprandial (fatty meal) right upper quadrant (RUQ) or epigastric pain lasting <6 hours, caused by transient cystic duct impaction. Normal laboratory values and no systemic inflammation.
- Acute Cholecystitis: Sustained cystic duct obstruction leading to gallbladder inflammation. Features constant RUQ pain, fever, leukocytosis, and a positive Murphy's sign (inspiratory arrest on deep RUQ palpation). Initial diagnostic test of choice is RUQ Ultrasound (showing gallbladder wall thickening >3 mm, pericholecystic fluid, and sonographic Murphy's sign). Treatment: Admission, NPO, IV fluids, broad-spectrum IV antibiotics (e.g., Ceftriaxone + Metronidazole), and early laparoscopic cholecystectomy (within 72 hours of admission).
- Choledocholithiasis: Gallstones in the common bile duct (CBD). Presents with RUQ pain, obstructive jaundice (elevated direct bilirubin, elevated Alkaline Phosphatase/GGT), and CBD dilation (>6 mm) on ultrasound. Treatment: Endoscopic Retrograde Cholangiopancreatography (ERCP) for stone extraction, followed by elective cholecystectomy.
- Ascending Cholangitis: Infection of an obstructed biliary tree. Classically presents with Charcot's Triad (Fever, RUQ pain, Jaundice). Progresses to Reynolds' Pentad (Charcot's Triad + Hypotension + Altered Mental Status), indicating life-threatening septic shock. Management: Emergency biliary decompression via urgent ERCP and broad-spectrum IV antibiotics.
Acute Pancreatitis
- Etiology: The two most common causes are Gallstones (~40%) and Alcohol consumption (~30%), followed by hypertriglyceridemia (>1000 mg/dL), ERCP complications, hypercalcemia, and medications (e.g., azathioprine, thiazides, furosemide).
- Diagnosis (Requires 2 of 3 criteria): (1) Severe epigastric pain radiating to the back; (2) Serum Lipase or Amylase ≥3 times upper limit of normal (Lipase is more specific and remains elevated longer); (3) Characteristic imaging findings on Contrast-Enhanced CT (CECT) of abdomen.
- Management: Aggressive IV fluid resuscitation with Lactated Ringer's solution (250-500 mL/hr initially), pain control, and early enteral nutrition (oral or nasogastric feeding preferred over TPN). Prophylactic antibiotics are not recommended for mild or sterile necrotizing pancreatitis.
Peptic Ulcer Disease (PUD) & Helicobacter pylori
Duodenal vs. Gastric Ulcers
- Duodenal Ulcers: Most common (~80%). Classically caused by H. pylori (~90%). Epigastric pain improves with meals and recurs 2-3 hours postprandially (or awakens patient at night). Rarely malignant.
- Gastric Ulcers: Often related to NSAID use or H. pylori. Epigastric pain worsens with meals, leading to food avoidance and weight loss. Biopsy is mandatory during endoscopy to rule out gastric adenocarcinoma.
H. pylori Eradication Regimens
Diagnostic confirmation: Non-invasive via Urea Breath Test or Stool Antigen Test (PPIs must be held for 2 weeks prior). Invasive via endoscopic mucosal biopsy (Rapid Urease / CLO test).
- First-line Therapy (14-day Bismuth Quadruple Therapy or Triple Therapy):
- Standard Triple Therapy (where clarithromycin resistance <15%): PPI BID + Amoxicillin 1g BID + Clarithromycin 500mg BID for 14 days. (Substitute Metronidazole for Amoxicillin in penicillin allergy).
- Bismuth Quadruple Therapy: PPI BID + Bismuth subsalicylate + Metronidazole + Tetracycline for 14 days.
- Post-treatment Verification: Eradication MUST be confirmed using Urea Breath Test or Stool Antigen Test at least 4 weeks after completing antibiotics and stopping PPI therapy.
Inflammatory Bowel Disease (IBD): Crohn's vs. Ulcerative Colitis
| Clinical & Pathological Feature | Ulcerative Colitis (UC) | Crohn's Disease (CD) |
|---|---|---|
| Anatomical Distribution | Restricted to Colon & Rectum. Begins at rectum and extends proximally in a continuous fashion. | Any part of GI tract from mouth to anus. Most common in terminal ileum & cecum. Sparing of rectum common. |
| Lesion Pattern | Continuous mucosal involvement. | Skip lesions (areas of normal bowel between diseased segments). |
| Depth of Inflammation | Superficial (Mucosal & Submucosal). | Transmural (extends through all layers of bowel wall). |
| Endoscopic Appearance | Erythematous, friable mucosa, pseudopolyps, loss of haustra ("lead pipe" colon). | Cobblestone appearance, aphthous ulcers, deep linear fissures, creeping fat. |
| Histological Hallmark | Crypt abscesses and mucosal ulcerations. | Noncaseating granulomas (~30%), transmural lymphoid aggregates. |
| Dominant Symptoms | Bloody diarrhea, tenesmus, crampy lower abdominal pain. | Non-bloody diarrhea, RLQ pain, weight loss, malabsorption (B12, bile salts). |
| Complications | Toxic megacolon (colon diameter >6 cm + systemic toxicity), Colorectal Cancer, Primary Sclerosing Cholangitis (PSC). | Fistulas (enterocutaneous, enterovesical), Strictures/Obstruction, perianal abscesses/fissures, gallstones, kidney stones. |
| Pharmacotherapy | Mild-Moderate: Topical/oral 5-ASA (Mesalamine). Acute flare: Corticosteroids. Maintenance: 5-ASA, Azathioprine, Anti-TNF (Infliximab). | Mild: Oral Budesonide/5-ASA. Moderate-Severe: Corticosteroids, Azathioprine/6-MP, Anti-TNF (Infliximab/Adalimumab). |
| Surgical Cure | Total Proctocolectomy is CURATIVE. | Surgery is non-curative; reserved for complications (strictures, fistulas, perforation). |
A 45-year-old female presents to the emergency department with a 12-hour history of severe, constant right upper quadrant abdominal pain, fever, and nausea. She reports the pain started after eating a heavy, fatty meal. On examination, she has a temperature of 38.5°C and marked tenderness in the RUQ with inspiratory arrest upon deep palpation. Laboratory tests show a WBC count of 14,000/μL. Liver function tests, including AST, ALT, alkaline phosphatase, and total bilirubin, are within normal limits. An abdominal ultrasound demonstrates gallbladder wall thickening of 5 mm, pericholecystic fluid, and multiple echogenic shadowing stones. What is the most appropriate next step in management?
A 28-year-old man presents with a 4-month history of chronic, non-bloody diarrhea, low-grade fevers, and an unintentional 5 kg weight loss. He also reports intermittent right lower quadrant abdominal pain. Laboratory investigations reveal a microcytic anemia, elevated ESR, and normal liver function tests. Colonoscopy with terminal ileal intubation is performed and reveals aphthous ulcers and cobblestone appearance in the terminal ileum, with patches of normal mucosa interspersed between diseased areas in the colon. Biopsy of the affected areas is most likely to show which of the following histological features?
A 55-year-old male presents with a 3-week history of worsening epigastric pain. The pain is described as a burning sensation that becomes more severe approximately 15 minutes after eating meals. He reports associated nausea and early satiety. He denies any melena or hematemesis. He has a history of osteoarthritis for which he takes ibuprofen regularly. An upper GI endoscopy is performed, revealing a 1.5 cm ulcerated lesion on the lesser curvature of the stomach. Biopsies of the ulcer edges are taken. What is the most important reason for obtaining these biopsies?